BR112016000231A8 - métodos para identificações de condições de separação com cromatografia de troca de íons e para análises de composições de polipeptídeos - Google Patents
métodos para identificações de condições de separação com cromatografia de troca de íons e para análises de composições de polipeptídeos Download PDFInfo
- Publication number
- BR112016000231A8 BR112016000231A8 BR112016000231A BR112016000231A BR112016000231A8 BR 112016000231 A8 BR112016000231 A8 BR 112016000231A8 BR 112016000231 A BR112016000231 A BR 112016000231A BR 112016000231 A BR112016000231 A BR 112016000231A BR 112016000231 A8 BR112016000231 A8 BR 112016000231A8
- Authority
- BR
- Brazil
- Prior art keywords
- separation conditions
- analysis
- methods
- ion exchange
- exchange chromatography
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 238000000926 separation method Methods 0.000 title abstract 3
- 238000004458 analytical method Methods 0.000 title 1
- 238000004255 ion exchange chromatography Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000013375 chromatographic separation Methods 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 238000012776 robust process Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8658—Optimising operation parameters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3847—Multimodal interactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Confectionery (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361845890P | 2013-07-12 | 2013-07-12 | |
| PCT/US2014/046338 WO2015006686A1 (en) | 2013-07-12 | 2014-07-11 | Elucidation of ion exchange chromatography input optimization |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112016000231A8 true BR112016000231A8 (pt) | 2019-12-31 |
Family
ID=51257626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016000231A BR112016000231A8 (pt) | 2013-07-12 | 2014-07-11 | métodos para identificações de condições de separação com cromatografia de troca de íons e para análises de composições de polipeptídeos |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US10274466B2 (enExample) |
| EP (2) | EP3536699A1 (enExample) |
| JP (2) | JP6462681B2 (enExample) |
| KR (1) | KR102251127B1 (enExample) |
| CN (1) | CN105377873B (enExample) |
| AU (1) | AU2014287044B2 (enExample) |
| BR (1) | BR112016000231A8 (enExample) |
| CA (1) | CA2918052A1 (enExample) |
| ES (1) | ES2705700T3 (enExample) |
| HR (1) | HRP20190071T1 (enExample) |
| IL (1) | IL243305B (enExample) |
| MX (1) | MX368107B (enExample) |
| PL (1) | PL3019516T3 (enExample) |
| RU (1) | RU2016104542A (enExample) |
| SG (1) | SG11201600221YA (enExample) |
| SI (1) | SI3019516T1 (enExample) |
| TR (1) | TR201818966T4 (enExample) |
| WO (1) | WO2015006686A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105377873B (zh) | 2013-07-12 | 2021-03-30 | 豪夫迈·罗氏有限公司 | 阐明离子交换层析输入优化 |
| WO2016075207A1 (en) * | 2014-11-12 | 2016-05-19 | Ge Healthcare Bio-Sciences Ab | Method and system for determining the influence of experimental parameters on a liquid chromatography protocol |
| GB2539420B (en) * | 2015-06-16 | 2021-01-13 | Cytiva Sweden Ab | Determination of chromatography conditions |
| SG11202009629YA (en) * | 2018-04-02 | 2020-10-29 | Amgen Inc | Erenumab compositions and uses thereof |
| EP3817756A4 (en) * | 2018-07-05 | 2022-03-30 | Ovation Diagnostics LLC | ANTI-BCL-2 ANTIBODIES AND IMMUNOLOGICAL ASSAY FOR THE DIAGNOSIS OF CANCER |
| KR20200080748A (ko) * | 2018-12-27 | 2020-07-07 | 주식회사 폴루스 | 음이온 교환 크로마토그래피를 이용한 인슐린 전구체의 정제방법 |
| WO2024261724A1 (en) * | 2023-06-23 | 2024-12-26 | Lupin Limited | Ion-exchange chromatography for separation and analysis of charge variants |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4666855A (en) * | 1985-07-31 | 1987-05-19 | Massachusetts Institute Of Technology | Rapid method for determining the isoelectric point for amphoteric molecules |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| DE3876273T2 (de) | 1987-04-11 | 1993-05-27 | Ciba Geigy Ag | Isoelektrisches fokussierverfahren sowie einrichtung zur durchfuehrung dieses verfahrens. |
| ES2058199T3 (es) | 1987-09-23 | 1994-11-01 | Bristol Myers Squibb Co | Heteroconjugados de anticuerpos para la eliminacion de celulas infectadas por el vih. |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| DE69029036T2 (de) | 1989-06-29 | 1997-05-22 | Medarex Inc | Bispezifische reagenzien für die aids-therapie |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US5229275A (en) | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
| EP0547065B1 (en) | 1990-06-29 | 2001-08-29 | Large Scale Biology Corporation | Melanin production by transformed microorganisms |
| US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
| JPH06507398A (ja) | 1991-05-14 | 1994-08-25 | リプリジェン コーポレーション | Ｈｉｖ感染治療のための異種複合抗体 |
| CA2103059C (en) | 1991-06-14 | 2005-03-22 | Paul J. Carter | Method for making humanized antibodies |
| MX9204374A (es) | 1991-07-25 | 1993-03-01 | Idec Pharma Corp | Anticuerpo recombinante y metodo para su produccion. |
| JP3951062B2 (ja) | 1991-09-19 | 2007-08-01 | ジェネンテック・インコーポレーテッド | 少なくとも遊離のチオールとして存在するシステインを有する抗体フラグメントの大腸菌での発現、２官能性Ｆ（ａｂ’）２抗体の産生のための使用 |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| FI941572L (fi) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| EP1136556B1 (en) | 1991-11-25 | 2005-06-08 | Enzon, Inc. | Method of producing multivalent antigen-binding proteins |
| EP1997894B1 (en) | 1992-02-06 | 2011-03-30 | Novartis Vaccines and Diagnostics, Inc. | Biosynthetic binding protein for cancer marker |
| JP3571337B2 (ja) | 1992-02-11 | 2004-09-29 | セル ジェネシス，インコーポレーテッド | 遺伝子標的現象による同型遺伝子接合 |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| CA2140280A1 (en) | 1992-08-17 | 1994-03-03 | Avi J. Ashkenazi | Bispecific immunoadhesins |
| PT752248E (pt) | 1992-11-13 | 2001-01-31 | Idec Pharma Corp | Aplicacao terapeutica de anticorpos quimericos e marcados radioactivamente contra antigenios de diferenciacao restrita de linfocitos b humanos para o tratamento do linfoma de celulas b |
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US5712374A (en) | 1995-06-07 | 1998-01-27 | American Cyanamid Company | Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates |
| KR100960211B1 (ko) | 1998-05-06 | 2010-05-27 | 제넨테크, 인크. | 이온 교환 크로마토그래피에 의한 단백질 정제 방법 |
| SE9803838D0 (sv) | 1998-11-09 | 1998-11-09 | Knut Irgum | A chromatography method and a column material useful in said method |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| US6451987B1 (en) * | 1999-03-15 | 2002-09-17 | Novo Nordisk A/S | Ion exchange chromatography of proteins and peptides |
| EP1175390B1 (en) | 1999-04-05 | 2005-02-02 | Emisphere Technologies, Inc. | Disodium salts, monohydrates, and ethanol solvates |
| WO2002051870A2 (en) | 2000-12-22 | 2002-07-04 | GRAD, Carole Legal Representative of KAPLAN, Howard | Phage display libraries of human vh fragments |
| JP2005289809A (ja) | 2001-10-24 | 2005-10-20 | Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) | 突然変異重鎖抗体 |
| JP5303092B2 (ja) | 2002-09-11 | 2013-10-02 | ジェネンテック， インコーポレイテッド | タンパク質精製 |
| AU2004241082A1 (en) | 2003-05-16 | 2004-12-02 | Cryobiophysica, Inc. | External gradient chromatofocusing |
| CA2529819A1 (en) | 2003-06-30 | 2004-09-23 | Domantis Limited | Pegylated single domain antibodies |
| US7906630B2 (en) | 2004-04-27 | 2011-03-15 | PerkinElmer Heath Sciences, Inc. | Method for identifying peptides in a biological sample |
| US7851742B2 (en) | 2004-05-20 | 2010-12-14 | Waters Technologies Corporation | Method and apparatus for identifying proteins in mixtures |
| CA2583081A1 (en) | 2004-06-16 | 2006-01-19 | Bio-Rad Laboratories, Inc. | Multichemistry fractionation |
| KR20070057839A (ko) | 2004-08-19 | 2007-06-07 | 제넨테크, 인크. | 변경된 이펙터 기능을 갖는 폴리펩티드 변이체 |
| AU2005279347A1 (en) * | 2004-08-30 | 2006-03-09 | Lonza Biologics Plc. | Affinity- plus ion exchange- chromatography for purifying antibodies |
| EP3088004B1 (en) | 2004-09-23 | 2018-03-28 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
| JP2006087394A (ja) * | 2004-09-27 | 2006-04-06 | Wako Pure Chem Ind Ltd | 核酸抽出方法および核酸抽出キット |
| GB0613753D0 (en) | 2006-07-11 | 2006-08-23 | Norwegian Radium Hospital Res | Method |
| JP2010089001A (ja) * | 2008-10-07 | 2010-04-22 | Japan Organo Co Ltd | クロマト分離方法 |
| SG174258A1 (en) | 2009-03-06 | 2011-10-28 | Genentech Inc | Antibody formulation |
| US20120177640A1 (en) | 2009-07-24 | 2012-07-12 | Josef Burg | Optimizing the production of antibodies |
| CN102686738A (zh) * | 2009-09-01 | 2012-09-19 | 弗·哈夫曼-拉罗切有限公司 | 通过改进的a蛋白洗脱增强的蛋白质纯化 |
| JP2013530406A (ja) * | 2010-07-09 | 2013-07-25 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | クロマトグラフィー方法及びそれに使用される媒体 |
| TW201235799A (en) | 2011-01-24 | 2012-09-01 | Sharp Kk | Exposure apparatus, liquid crystal display device and method for manufacturing same |
| CA2831429A1 (en) | 2011-03-31 | 2012-10-04 | Apotex Technologies Inc. | Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma- glutamyl-l-tryptophan |
| CA2890979A1 (en) | 2012-11-15 | 2014-05-22 | Genentech, Inc. | Ionic strength-mediated ph gradient ion exchange chromatography |
| CN105377873B (zh) | 2013-07-12 | 2021-03-30 | 豪夫迈·罗氏有限公司 | 阐明离子交换层析输入优化 |
-
2014
- 2014-07-11 CN CN201480039460.3A patent/CN105377873B/zh active Active
- 2014-07-11 KR KR1020167003178A patent/KR102251127B1/ko active Active
- 2014-07-11 EP EP18204792.8A patent/EP3536699A1/en not_active Withdrawn
- 2014-07-11 AU AU2014287044A patent/AU2014287044B2/en active Active
- 2014-07-11 SI SI201431039T patent/SI3019516T1/sl unknown
- 2014-07-11 SG SG11201600221YA patent/SG11201600221YA/en unknown
- 2014-07-11 CA CA2918052A patent/CA2918052A1/en not_active Abandoned
- 2014-07-11 EP EP14745049.8A patent/EP3019516B1/en active Active
- 2014-07-11 US US14/904,422 patent/US10274466B2/en active Active
- 2014-07-11 BR BR112016000231A patent/BR112016000231A8/pt active Search and Examination
- 2014-07-11 TR TR2018/18966T patent/TR201818966T4/tr unknown
- 2014-07-11 RU RU2016104542A patent/RU2016104542A/ru not_active Application Discontinuation
- 2014-07-11 WO PCT/US2014/046338 patent/WO2015006686A1/en not_active Ceased
- 2014-07-11 ES ES14745049T patent/ES2705700T3/es active Active
- 2014-07-11 PL PL14745049T patent/PL3019516T3/pl unknown
- 2014-07-11 HR HRP20190071TT patent/HRP20190071T1/hr unknown
- 2014-07-11 MX MX2016000181A patent/MX368107B/es active IP Right Grant
- 2014-07-11 JP JP2016525805A patent/JP6462681B2/ja active Active
-
2015
- 2015-12-23 IL IL243305A patent/IL243305B/en active IP Right Grant
-
2018
- 2018-12-26 JP JP2018242206A patent/JP2019090818A/ja active Pending
-
2019
- 2019-03-12 US US16/351,372 patent/US10921297B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3019516A1 (en) | 2016-05-18 |
| WO2015006686A1 (en) | 2015-01-15 |
| TR201818966T4 (tr) | 2019-01-21 |
| EP3536699A1 (en) | 2019-09-11 |
| KR20160030251A (ko) | 2016-03-16 |
| EP3019516B1 (en) | 2018-11-14 |
| SG11201600221YA (en) | 2016-02-26 |
| IL243305A0 (en) | 2016-03-31 |
| US20160161455A1 (en) | 2016-06-09 |
| WO2015006686A8 (en) | 2018-10-04 |
| US10921297B2 (en) | 2021-02-16 |
| PL3019516T3 (pl) | 2019-04-30 |
| JP6462681B2 (ja) | 2019-01-30 |
| CN105377873B (zh) | 2021-03-30 |
| HK1222183A1 (zh) | 2017-06-23 |
| ES2705700T3 (es) | 2019-03-26 |
| US20190310234A1 (en) | 2019-10-10 |
| MX368107B (es) | 2019-09-18 |
| US10274466B2 (en) | 2019-04-30 |
| AU2014287044B2 (en) | 2020-02-06 |
| JP2016529489A (ja) | 2016-09-23 |
| AU2014287044A1 (en) | 2016-02-11 |
| JP2019090818A (ja) | 2019-06-13 |
| MX2016000181A (es) | 2016-03-09 |
| CA2918052A1 (en) | 2015-01-15 |
| KR102251127B1 (ko) | 2021-05-11 |
| SI3019516T1 (sl) | 2019-02-28 |
| HRP20190071T1 (hr) | 2019-02-22 |
| RU2016104542A (ru) | 2017-08-17 |
| CN105377873A (zh) | 2016-03-02 |
| IL243305B (en) | 2019-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112016000231A8 (pt) | métodos para identificações de condições de separação com cromatografia de troca de íons e para análises de composições de polipeptídeos | |
| BR112017017025A2 (pt) | métodos e composições para analizar componentes celulares | |
| BR112014010955A2 (pt) | sistema e método para processar amostras | |
| EA201590027A1 (ru) | Способы детекции заболеваний или состояний | |
| GB2526736A (en) | Methods, compositions, and kits for nucleic acid analysis | |
| BR112017018821A2 (pt) | métodos para quantificação de níveis de insulina através de espectrometria de massa | |
| BR112017010406A2 (pt) | processo de realização de teste de alta produtividade de cromatografia líquida de alta eficiência | |
| EP3160609A4 (en) | Automated sample fractionation prior to mass spectrometric analysis | |
| WO2014144822A3 (en) | Methods and compositions for tagging and analyzing samples | |
| HK1220227A1 (zh) | 与als有关的重复含有蛋白质的二氨基酸 | |
| MX2016016904A (es) | Analisis de secuencias de acidos nucleicos. | |
| MX388164B (es) | Anticuerpos y fragmentos anti-vista | |
| BR112015001592A8 (pt) | análise de imagem e medidas de amostras biológicas | |
| BR112016027475A2 (pt) | kit, dispositivo e método para a detecção de câncer pancreático | |
| IL253666A0 (en) | Hyperspectral testing device for testing different types of samples | |
| GB2552398B (en) | Multi-dimensional chromatographic system for analyzing multiple sample components | |
| EP3236243A4 (en) | System for analyzing online-transferred assay samples | |
| GB201305639D0 (en) | A method of mass spectrometry and a mass spectrometer | |
| BR112017002622A2 (pt) | métodos e sistemas para quantificação seletiva e detecção de alergênicos | |
| EP3385709A4 (en) | Liquid sample analysis system | |
| EP3304058C0 (en) | Reagents for quantitative mass spectrometry | |
| EP3264093A4 (en) | Method for diagnosing diseases through oligomer analysis of abnormally aggregated proteins | |
| BR112017013256A2 (pt) | método de análise, portador de amostra em forma de disco e aplicação de um portador de amostra | |
| MX2016007148A (es) | Metodos de ensayo de beta-glucano. | |
| EP2935663A4 (en) | MICROPOWER ARRANGEMENTS FOR MYELINIZATION TESTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |